Ultragenyx Pharmaceutical Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Ultragenyx Pharmaceutical Inc. Return On Assets for the quarter ending September 30, 2024 was -37.6 %, a 19.1% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2023 was -44.7 %, a 7.22% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2022 was -48.2 %, a 62.4% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Return On Assets for 2021 was -29.7 %, a 122% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -44.7 +3.48 +7.22% Jan 1, 2023 Dec 31, 2023
2022 -48.2 -18.5 -62.4% Jan 1, 2022 Dec 31, 2022
2021 -29.7 -16.3 -122% Jan 1, 2021 Dec 31, 2021
2020 -13.4 +27.1 +66.9% Jan 1, 2020 Dec 31, 2020
2019 -40.5 -15 -59.1% Jan 1, 2019 Dec 31, 2019
2018 -25.4 +35.9 +58.6% Jan 1, 2018 Dec 31, 2018
2017 -61.4 -13.7 -28.7% Jan 1, 2017 Dec 31, 2017
2016 -47.7 -16.4 -52.4% Jan 1, 2016 Dec 31, 2016
2015 -31.3 +0.84 +2.61% Jan 1, 2015 Dec 31, 2015
2014 -32.1 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.